SPS IPC Drives 2015, Hall 11
Siemens has developed the Siplus CMS1200 Condition Monitoring System to monitor mechanical components. It is an expansion module for the S7-1200 controller that is based on the SM 1281 Condition Monitoring Module.
The user creates an efficient monitoring system by combining up to seven SM 1281 modules, to each of which four vibration acceleration sensors and one speed measurement sensor can be connected. This system can be used for continuous monitoring of mechanical components such as motors, generators, pumps and fans.
When Siplus CMS1200 is used for predictive maintenance, significant changes as a result of wear, for example, can consequently be detected at an early stage, enabling maintenance activities to be better planned and carried out on schedule.
By means of the TIA Portal (Totally Integrated Automation) engineering framework, the Siplus CMS1200 Condition Monitoring System is readily integrated into an automation group containing HMI (human machine interface) devices, controls and motion control components.
The recorded signals are easily evaluated with the CMS analytical software on the SM 1281 modules, or archived with a time stamp in the 800 MB memory for further analysis. Trend values, raw data, frequency ranges and messages can be recorded.
The versatile analytical capabilities of Siplus CMS1200 range from parameter-based, frequency-selective analyses, through trend analyses, to monitoring the limits of frequency ranges. The fingerprint comparison makes it easy to localize damage.
The parameter-based diagnostics run directly on the S7-1200 CPU for easy monitoring. These diagnostics are performed directly on the SM 1281 module and can be accessed by web browser to avoid the production cycle being burdened by detailed, frequency-selective diagnostics.
For further information, please see www.siemens.com/siplus-cms
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of €7.4 billion. At the end of September 2015, the company had around 348,000 employees worldwide.
Further information is available on the Internet at www.siemens.com
Reference Number: PR2015110054DFEN
Mr. Gerhard Stauss
Digital Factory Division
Gleiwitzer Str. 555
Tel: +49 (911) 895-7945
Gerhard Stauß | Siemens Digital Factory
Special exhibition area "Microtechnologies for Optical Devices" establishes itself at W3
12.03.2020 | IVAM Fachverband für Mikrotechnik
Augmented reality system facilitates manual manufacturing of products made of fiber-reinforced composite materials
04.03.2020 | Fraunhofer-Institut für Produktionstechnologie IPT
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Life Sciences
29.05.2020 | Physics and Astronomy
29.05.2020 | Life Sciences